DAN SCHLAGER, MD, FACEP

Curriculum Vitae

EDUCATION:

1982-1986
School of Medicine and Health Sciences – MD
George Washington University
Washington, D.C.

1985
National Hospital Institute of Neurology
University of London
London, England

1977-1981
Brandeis University
Waltham, MA

CERTIFICATION:

National Board of Medical Examiners
Advanced Trauma and Life Support
ATLS Certified - not current
ACLS Certified - current
APLS Certified - current
PALS Certified - current
Emergency Board Certified – Recertified 2008
SCTW-95 Certified – current

PROFESSIONAL EXPERIENCE:

2016-Present
Adjunct Professor/Department of Emergency Medicine
University of Arizona
Tucson, Arizona

2016-Present
Medical Director/Investigator
St Johns Center for Clinical Research
Ponte Vedra, FL

2015-2016
Phase 1 Medical Director
Jacksonville Center for Clinical Research (JCCR)
Jacksonville, FL

2015-Present
Investigator
Jacksonville Center for Clinical Research (JCCR)
Jacksonville, FL

2011
Program in Innovation and Entrepreneurship
Stanford University as PRIE Fellow

2010-Present
President and Founder
Zoltar Technology, Inc.
Medical Device Development

Patents and Technology Consultant
Mosaid Technologies, Inc.
Ottawa, Canada

2009/2010/2011/2015
Expedition Physician
National Geographic/Lindbald

2007-Present
Camp Physician Bohemian Club

2004-2009
Kaiser Petaluma Urgent Care

2002
Marin General Emergency Department

1997
Emergency Department
California Pacific Medical Center
San Francisco, California

1995
Assistant Chief Kaiser Santa Rosa

1995-2010
President and Founder
Zoltar Satellite Alarm Systems, Inc.
GPS Patent Award, Development, Licensing, Successful Sale

1994
Assistant Clinical Professor of Medicine
UCSF School of Medicine
University of California, San Francisco

1990-1992
Lifeflight Helicopter Physician
Stanford University
Stanford, California

1989-2016
Emergency Department
Kaiser Foundation Hospital
Santa Rosa, California

POST DOCTORAL TRAINING:

1987
Department of Plastic Surgery and Burn Unit
University of Copenhagen
Copenhagen, Denmark

1986-1989
Residency (Chief Resident 1988-1989)
Department of Emergency Medicine
University of Arizona Health Sciences Center
Tucson, Arizona

AWARDS:

2011
Stanford University Graduate School of Business – PRIE Fellow

1999
Nominated for Inventor of the Year by the Intellectual Property Organization

1998
Best New Electronics Device – Hammacher Schlemmer

1988
Chief Resident, University of Arizona Dept. of Emergency Medicine

1977
Cum Laude, Brandeis University

1977
Phi Beta Kappa, Brandeis University

MANUSCRIPTS:

  1. Schlager D, Sanders AB, Wiggins D, Boren W. Ultrasound for the detection of foreign bodies. Annals of Emergency Medicine. February 1991. Volume 20, Issue 2, Pages 189-191.
  2. Schlager D, Iserson KV. Emergency burn treatment in Denmark. The Journal of Emergency Medicine. November-December 1988. Volume 6, Issue 6, Pages 517-519.
  3. Schlager D. Ultrasound detection of foreign bodies and procedure guidance. Emergency Medicine Clinics of North America. November 1997. Volume 15, Issue 4, Pages 895-912.
  4. Schlager D, Whitten D, Tolan K. Emergency department ultrasound: Impact on ed stay times. The American Journal of Emergency Medicine. March 1997. Volume 15, Issue 2, Pages 216-217.
  5. Schlager D, Johnson T, McFall R. Safety of Imaging Exploding Bullets with Ultrasound. Annals ofMedicine. August 1996. Volume 28, Issue 2, Pages 183-187.
  6. Schlager D, Lazzareschi G, Whitten D, Sanders AB. A prospective study of ultrasonography in the ED by emergency physicians. March 1994. The American Journal of Emergency Medicine. Volume 12, Issue 2, Pages 185-189.

ABSTRACTS:

  1. Schlager D. Effect of theophylline on exercise-induced myocardial ischemia: Crea F, Galassi AR, Kaski JC, et al Lancet 683-686 Apr 1989. Annals of Emergency Medicine. October 1989. Volume 18, Issue 10, Page 1129.
  2. Schlager D. Can you rely on condoms?: Consumer’s Union Consumer Reports, 135-141 Mar 1987. Annals of Emergency Medicine. October 1989. Volume 18, Issue 10, Page 1132.
  3. Schlager D. Protective effects of rear seat restraints during car collision: Bodiwala GG, Thomas PD, Otubushin A Lancet 369-371 Feb 18, 1989. Annals of Emergency Medicine. August 1989. Volume 18, Issue 8, Pages 904-905.
  4. Schlager D. Serum theophylline testing in a pediatric emergency setting: Potential benefit of rapid assays: Shaw KN, Fleisher GR, Schwartz S J Ped Emerg Care 14;4:237-240 Dec 1988. Annals of Emergency Medicine. June 1989. Colume 18, Issue 6, Page 715.
  5. Schlager D. Intravenous β-agonist in severe acute asthma: Cheang B, Reynolds SR, Ryan G, et al Br Med J 297:448 Aug 13, 1988. Annals of Emergency Medicine. April 1989. Volume 18, Issue 4, Page 431.
  6. Schlager D. Comparison of mosquito nets, proguanil hydrochloride, and placebo to prevent malaria: Nesill CG, Watkins WM, Carter JY, et al Br Med J 297:401-403 Aug 1988. Annals of Emergency Medicine. February 1989. Volume 18, Issue 2, Pages 224-225.
  7. Schlager D. Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections: Hoepelman I, Rozenberg-Arska M, Verhoef J Lancet 1305-1309 June 11, 1988. Annals of Emergency Medicine. December 1988. Volume 17, Issue 12, Page 1361.
  8. Schlager D. The role of IVP in blunt trauma: Wong L, Smolin M, et al J Trauma 28;4:502-504 Apr 1988. Annals of Emergency Medicine. October 1988. Volume 17, Issue 10, Pages 1126-1127.
  9. Schlager D. Revaccination against tetanus 17 to 20 years after primary vaccination: Kinetics of antibody response: Simonsen O, Klaerke M, Jensen JEB, et al J Trauma 27:1358-1361 Dec 1987. Annals of Emergency Medicine. August 1988. Volume 17, Issue 8, Page 863.
  10. Schlager D. Negligible sublingual absorption of nifedipine: van Harter J, Burggraaf K, Danhof M, et al Lancet 1363-1364 Dec 1987. Annals of Emergency Medicine. June 1988. Volume 17, Issue 6, Page 656.
  11. Schlager D. Paramedic perception of elapsed field time: Jurkovich G, Campbell D, Padrta J, et al. J Trauma 27:892-896 Aug 1987. Annals of Emergency Medicine. April 1988. Volume 17, Issue 4, Page 376.
  12. Schlager D. Urine culturing techniques in febrile infants: Bonadio WA Pediatr Emerg Care 3:75-75 Jun 1987. Annals of Emergency Medicine. February 1988. Volume 17, Issue 2, Page 182.
  13. Schlager D. Misuse of intravenous verapamil in patients with ventricular tachycardia: Rankin AC, Rae AP, Cobbe SM Lancet 2:472-473 Aug 1987. Annals of Emergency Medicine. February 1988. Volume 17, Issue 2, Pages 181-182.

COMMITTEES/TEACHING:

National speaker and writer about the emerging role of cellular phones as a personal safety device and its effects on Emergency Medicine
Wilderness Medical Society, 2009
Wireless Emergency Services Conference – Preparing for Phase 2 Implementation, January, Orlando, FL
Wireless Emergency Services Conference – Emerging role of GPS in Emergency Care, Kansas City, MO

ULTRASOUND TEACHING:

Ultrasound course coordinator-Diagnostic Ultrasonography for Emergency Physicians ACEP National Faculty member for teaching Ultrasound at State and National meetings. Lectured at Universities, State, National and International meetings on the role of ultrasound in Emergency Medicine. Conferences include SAEM Scientific Assembly, Toronto, 1992, California ACEP Annual Meeting Palm Springs 1992, San Diego 1993, Squaw Valley 1994, Santa Barbara 1995, Oregon ACEP 1994, National ACEP Ultrasound Conference St. Louis, 1993, Kaiser National Conference, San Francisco 1993, Beaver Creek 1994, Maui 1995, SDMS Colorado Springs 1995.

PATENTS:

2013
Patent No.: US 20130298319 A1
Cardiopulmonary lightning protection garment
Filing Date: May 10, 2012; Published: November 14, 2013

2012
Patent No.: US 20120089023 A1
Parameter-sensing endotracheal tube
Filing Date: June 11, 2011; Published: April 12, 2012

2012
Patent No.: US 20120089041 A1
Ultrasound-observable, respiratory gas-warming, parameter-sensing endotracheal tube
Filing Date: October 9, 2010; Published: April 12, 2012

2012
Patent No.: 8, 149, 112
Multihazard Alarm System Using Selectable Power Level Transmission and Localization
Filing Date: July 25, 2006; Issued: April 3, 2012

2008
Patent No.: EP0857341 B1
Self-Locating Remote Monitoring Systems
Filing Date: October 28, 1996; Issued: July 30, 2008

2004
Patent No.: US 20040027245 A1
Portable, self-locating smart defibrillator system
Filing Date: August 10, 2002; Published: February 12, 2004

2004
Patent No.: US 20040113794 A1
Self-locating personal alarm system equipped parachute
Filing Date: October 27, 2003; Published: June 17, 2004

2003
Patent No.: US 20030102972 A1
Self-locating personal alarm system equipped parachute
Filing Date: December 4, 2001; Published: June 5, 2003

2003
Patent No.: US 6518889 B2
Voice-activated personal alarm
Filing Date: December 1, 2000; Issued: February 11, 2003

2001
Patent No.: 6, 198, 390
Self-Locating Remote Monitoring Systems
Filing Date: June 3, 1999; Issued: March 6, 2001

1999
Patent No.: 5, 963, 130
Self-Locating Remote Systems
Filing Date: July 6, 1998; Issued: October 5, 1999

1997
Patent No.: US 5650770 A
Self-locating remote monitoring systems
Filing Date: October 23, 1995; Issued: July 22, 1997

1995
Patent No.: US 5461365 A
Multi-hazard alarm system using selectable power-level transmission and localization
Filing Date: October 27, 1994; Issued: October 24, 1995

RESEARCH TRAINING:

8/16/2016
Pfizer SIRIUS for Safety Reporting Training

7/21/2016
REVEAL-TIMI 55 Protocol Training

7/21/2016
Novo Nordisk InForm 6.0 training for Inv. Approval only_v2

7/5/2016
Pfizer Complete Statin Intolerance IRT Stratification Training version 1.0

10/16/2015
Novartis CLHW090X2202 Timaeus 5 Release 3 Training Certificate of Completion

10/14/2015
Pfizer B1481022 Protocol Overview Certificate of Completion

7/15/2015
Pfizer Neuropathy Impairment Score (NIS) Training

2015
CITI Good Clinical Practice Training

11/13-14/2015
Clinical Investigator Training Sponsored by Encore Research Group; Jacksonville FL
12 CME/Certificate provided

PREVIOUS RESEARCH EXPERIENCE:

Clinical Investigator in 1997 for Dermabond, the first tissue adhesive for wound closure.

Principal Investigator at Kaiser Santa Rosa, which was one of 4 emergency medicine sites in the United States to perform clinical trials enabling the approval of this new device for wound closure.

Consulted for ultrasound companies, including Hewlett-Packard, Siemens, and Aloka. Provided training and independent research in the use of emergency department ultrasound.

Clinical Investigator in 1989 at University of Arizona, Tucson, Arizona for the Temafloxacin study.

SJCCR RESEARCH EXPERIENCE:

2016-Present
Principal Investigator: Sanofi, LPS14355, Lipids treatment in diabetics

2016-Present
Principal Investigator:Sanofi Pasteur MET49, Meningococcal vaccine

2016-Present
Principal Investigator: Pfizer, B1481022, Hyperlipidemia/CV Events

2016-Present
Principal Investigator: Pfizer, B1481038, Hyperlipidemia/ CV Events

2016-Present
Sub-Investigator: Amgen 20130385, Cognitive Sub-Study

2016-Presen
Sub-Investigator: Amgen 20110118, Hypercholesterolemia

2016-Presen
Sub-Investigator: Amgen 20110110, Hypercholesterolemia

2016-Present
Sub-Investigator: Amgen 20130295, Open Label Extension to Amgen 20110118, Hypercholesterolemia

JCCR RESEARCH EXPERIENCE:

2016-Present
Sub-Investigator: Astellas, 5094-CL-0102 Rheumatoid Arthritis Phase 1

2016-Present
Sub-Investigator: Sanofi EFC11570, Acute Coronary Syndrome

2015-Present
Sub-Investigator: Actavis AV01.2015-0863, OA of the Knee

2015-Present
Sub-Investigator: MedImmune D5780C00002, Coronary Artery Disease

2015-2016
Sub-Investigator: AnGes AG-CLI-0206, Critical Limb Ischemia

2015-Present
Sub-Investigator: MedImmune D6240C00001, Type 2 Diabetes

2015-Present
Sub-Investigator: Novartis CLHW090X2202, Resistant HTN

2015-2016
Sub-Investigator: Arbor AR06.009, Heart Failure Phase 1

2015-Present
Sub-Investigator: Amgen, 20140254, Chronic stable angina

2015-Present
Sub-Investigator: Pfizer, B1481022, Hyperlipidemia/CV Events

2015-Present
Sub-Investigator: Pfizer, B1481038, Hyperlipidemia/ CV Events

2015-2016
Sub-Investigator: Sanofi CUP14366, Compassionate Use Protocol, Hypercholesterolemia

2015-Present
Sub-Investigator: AbbVie M13-741, Knee Osteoarthritis

2015-Present
Sub-Investigator: Acorda, GGF2-CV-1007, Heart Failure Phase 1

2015-2016
Sub-Investigator: Novartis CRLX030A2209, Heart Failure